| Not Yet Recruiting | A Single-Arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte Injection (GT307) in the Treatment of Advanced Solid Tumors | N/A | 2026-04-30 |
| Recruiting | A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immu IgA Nephropathy (IgAN), Membranous Nephropathy, ANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN) | EARLY_Phase 1 | 2026-01-31 |
| Recruiting | A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in the Treatment of Refr cGVHD | EARLY_Phase 1 | 2025-12-18 |
| Recruiting | A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Moderate to Severe Refractory Autoimmune Disease | EARLY_Phase 1 | 2025-11-07 |
| Recruiting | GT719 Injection for Moderate to Severe Refractory Autoimmune Disease Auto Immune Disease | EARLY_Phase 1 | 2025-10-28 |
| Recruiting | A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refract B-cell Acute Lymphoblastic Leukemia (B-ALL), Chronic Lymphocytic Leukemia (CLL), B-cell Non-Hodgkin's Lymphoma (B-NHL) | EARLY_Phase 1 | 2025-09-26 |
| Recruiting | GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases Autoimmune Diseases | EARLY_Phase 1 | 2025-08-22 |
| Recruiting | GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies Hematological Malignancy (Leukemia- Lymphoma) | Phase 1 / Phase 2 | 2025-04-18 |
| Recruiting | A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants Wi Hematological Malignancy (Leukemia- Lymphoma) | EARLY_Phase 1 | 2025-03-10 |
| Recruiting | GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases Neurological Autoimmune Diseases | Phase 1 | 2025-01-14 |
| Recruiting | IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma Advanced Clear Renal Cell Carcinoma, Adult | Phase 1 | 2024-12-06 |
| Recruiting | Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients with Advanced Lung Ade Advanced Lung Adenocarcinoma；Adult | Phase 1 | 2024-07-18 |
| Recruiting | Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients with Advanced Lung Cancer Adult, Lung Cancer | N/A | 2024-07-18 |
| Recruiting | Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours Adult | N/A | 2024-07-04 |
| Recruiting | Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced Colorectal Cancer Adult | N/A | 2024-06-28 |
| Recruiting | Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors HNSCC | N/A | 2024-05-12 |
| Recruiting | Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours Solid Tumor, Adult | N/A | 2024-04-18 |
| Recruiting | Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Adult | Phase 2 | 2024-04-02 |
| Recruiting | GT201 Injection in Combination with Teraplizumab Injection for Treatment of Patients with Non-small Cell Lung Adult, Non-small Cell Lung Cancer | N/A | 2024-02-02 |
| Recruiting | GT201 Injection For The Treatment Of Advanced Solid Tumors Solid Tumor, Adult | Phase 1 / Phase 2 | 2023-09-13 |
| Recruiting | Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (advanced Cervical Cancer) Adult, Gynecological Tumors | N/A | 2023-06-05 |
| Recruiting | Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Soli Solid Tumor, Gynecological Tumors | N/A | 2023-03-09 |
| Recruiting | Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors Solid Tumor, Adult, GT316 | EARLY_Phase 1 | 2023-02-26 |
| Recruiting | Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors Adult Gynecological Tumors | EARLY_Phase 1 | 2022-11-01 |
| Recruiting | Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors Solid Tumor | Phase 1 / Phase 2 | 2022-09-14 |
| Recruiting | GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors Solid Tumors, Adult | Phase 1 | 2022-05-23 |
| Recruiting | Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/recurrent Advanced Solid Tumor | Phase 1 | 2022-01-04 |
| Recruiting | GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors Adult | EARLY_Phase 1 | 2021-07-05 |
| Recruiting | TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors Solid Tumors, Adult | Phase 1 | 2021-04-21 |